Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF.
Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks.
Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis.
Identification of Selective Inhibitors of the Potassium Channel Kv1.1-1.2((3)) by High-Throughput Virtual Screening and Automated Patch Clamp.
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study.
The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.
Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis.
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
Novel Immune Regulator Shows Promise as MS Therapy in Clinical Trials
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population.
Meralgia paresthetica after subcutaneous injection of glatiramer acetate.
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
A molecular link between the active component of marijuana and Alzheimer's disease pathology.
Cranial neuropathies in multiple sclerosis defined by magnetic resonance imaging and fludeoxyglucose f 18 positron emission tomography.
Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands.
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Multiple sclerosis.

Pages